bioMérieux S.A. (EPA:BIM)
France flag France · Delayed Price · Currency is EUR
69.00
+1.45 (2.15%)
Jun 19, 2026, 5:37 PM CET

bioMérieux Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, bioMérieux stock has a consensus rating of "Hold" and an average price target of €90.43. The average 1-year stock price forecast is 31.06% higher than the current stock price, while the lowest is €71.60 (+3.77%) and the highest is €110.00 (+59.42%).

Price Target: €90.43 (+31.06%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price€71.60€90.43€90.00€110.00
Change+3.77%+31.06%+30.43%+59.42%

Analyst Ratings

The average analyst rating for bioMérieux stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy554332
Buy011111
Hold878989
Sell000000
Strong Sell000000
Total131313131212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Hold
Downgrades
€138.00€80.00
HoldDowngrades€138.00€80.00+15.94%Jun 1, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
€120.50€71.60
HoldMaintains€120.50€71.60+3.77%Apr 24, 2026
Deutsche Bank
Deutsche Bank
Hold
Downgrades
€120.00€81.00
HoldDowngrades€120.00€81.00+17.39%Apr 24, 2026
Barclays
Barclays
Hold
Maintains
€100.00€90.00
HoldMaintains€100.00€90.00+30.43%Apr 23, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
€109.00€100.00
HoldMaintains€109.00€100.00+44.93%Apr 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.11B
from 4.07B
Increased by 1.10%
Revenue Next Year
4.38B
from 4.11B
Increased by 6.51%
EPS This Year
4.41
from 4.64
Decreased by -4.94%
EPS Next Year
4.92
from 4.41
Increased by 11.52%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
3.38B3.59B3.67B3.98B4.07B4.11B
Revenue Growth
8.27%6.31%2.39%8.31%2.26%1.10%
Gross Profit
2.00B2.01B2.06B2.22B2.31B2.30B
Gross Margin
59.26%55.97%55.99%55.66%56.73%55.97%
Operating Income
813.50M613.00M569.00M637.90M694.80M683.29M
Net Income
601.10M452.40M357.60M432.20M397.50M504.24M
EPS
----4.644.41
EPS Growth
----22.16%-4.94%
Forward PE
31.2525.4823.6023.0522.6215.64
Dividend / Share
0.850.850.850.900.981.11
Dividend Growth
---5.88%8.89%12.84%
Free Cash Flow
389.05M206.36M152.25M297.69M615.78M472.98M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High4.2B
Avg4.1B
Low3.9B

Revenue Growth

Revenue Growth202620272028
High
4.2%
Avg
1.1%
Low
-3.1%

EPS Forecast

EPS202620272028
High4.76
Avg4.41
Low4.13

EPS Growth

EPS Growth202620272028
High
2.6%
Avg
-4.9%
Low
-11.0%